(Alliance News) - Oxford BioMedica PLC on Wednesday said loss widened in the first half of 2023 as revenue fell, while it noted being in exclusive talks to buy ABL Europe from Institut Merieux SA for EUR15 million. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced this week and not separately reported by Alliance News: Read More
(Alliance News) - The FTSE 100 was boosted by retailers and housebuilders midday Wednesday, as investors celebrated UK inflation easing to an 18-month low in a development that takes some pressure off the Bank of England. Read More
Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Launches its 4th generation lentiviral vector delivery system, TetraVecta. Says the TetraVecta system enhances the development of more effective lentiviral vector-based therapies. Firm says this enables cell and gene therapy companies to overcome previous barriers in therapeutic development. Read More
(Alliance News) - Oxford BioMedica PLC on Tuesday reported a drop in annual revenue and swung to a loss, as a result of lower volumes and higher costs. Read More
(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
